The Rising respiratory diseases are Propelling the Growth of the Dextromethorphan Market in the APAC Region!
- Himanshu Patni
- July 15, 2023
- HEALTHCARE, NEWS
- Dextromethorphan Market, Dextromethorphan Market Forecast, Dextromethorphan Market Growth, Dextromethorphan Market Share, Dextromethorphan Market Size, Dextromethorphan Market Trends
- 0 Comments
The Asia Pacific dextromethorphan market is a significant contributor to the global dextromethorphan market, which is expected to grow significantly during the forecast period. The increasing incidences of respiratory diseases, along with the increasing population in the region are among the important driving factors for the dextromethorphan market in the region. Furthermore, countries such as China and India are considered as the hub for the generic medicine development and the growth of the industry in the region is also a key factor driving the market growth in the region.
Access sample report (including graphs, charts, and figures): https://univdatos.com/report/dextromethorphan-market/get-a-free-sample-form.php?product_id=41500
Further, the Asia-Pacific Dextromethorphan Market is expected to grow at a strong CAGR of 3% during the forecast period (2023-2030). The growing population and rising respiratory diseases among them are the major reason for the market growth of Dextromethorphan in the Asia-Pacific.
FIG. 1 APAC Dextromethorphan Market Revenue (2020-2030)- USD Mn
For a detailed analysis of Global Dextromethorphan Market browse through – https://univdatos.com/report/dextromethorphan-market/
Based on product type, the market is segmented into capsules, tablets, syrups, and others. As per our analysis, the tablets segment acquired a major share in 2022. Tablets are also widely used as cough suppressants and are available over the counter in most countries. Tablets offer various advantages such as increasing the transfer of controlled doses of drugs and being more convenient to use is the major factor responsible for the growth of the segment.
Based on the age group, the market is segmented into adults and pediatrics. The pediatric segment is expected to grow with a higher CAGR in the dextromethorphan market during the forecast period. The demand for pediatric DXM products is driven by the high incidence of respiratory infections in children, which can cause coughing and sneezing. In addition, many parents prefer to use OTC medications, such as DXM products, to treat their children’s symptoms rather than seeking prescription medications.
Based on the distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, online pharmacy, and others. As per our analysis, the retail pharmacy segment acquired a major share in 2022. Retail pharmacies also play a critical role in ensuring that DXM products are used appropriately and safely. Pharmacists can provide information on proper dosing and use, as well as warn consumers about the potential risks associated with DXM use. These are the several factors that are driving the growth of the retail pharmacy segment.
Global Dextromethorphan Market Segmentation
Market Insight, by Product Type
- Capsule
- Tablet
- Syrups
- Others
Market Insight, by Age Group
- Adults
- Pediatric
Market Insight, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Market Insight, by Region
- North America
- U.S.
- Canada
- Rest of North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- APAC
- China
- Japan
- India
- Rest of APAC
- Rest of the World
Top Company Profiles
• Aurobindo Pharma
• Mylan N.V.
• Sandoz International GmbH
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Zydus Group
• Cipla Inc
• Amneal Pharmaceuticals LLC
• Pfizer Inc.
• Intas Pharmaceuticals Ltd.
